Nowadays, the research interest has focused on the prognostic value of Ang-2 in lung cancer, while it has been proposed that Ang-2 can be regarded as an indicator of poor prognosis of NSCLC [16]. This evidence concerns the gene ANGPT2 and lung carcinoma.